BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes
- PMID: 19641504
- PMCID: PMC2928562
- DOI: 10.1038/onc.2009.40
BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes
Abstract
BIK is the founding member of the BH3-only family pro-apoptotic proteins. BIK is predominantly localized in the ER and induces apoptosis through the mitochondrial pathway by mobilizing calcium from the ER to the mitochondria and remodeling the mitochondrial cristae. BIK-mediated apoptosis is mediated by selective activation of BAX. BIK also induces non-apoptotic cell death in certain cell types by unknown mechanisms. BIK is non-essential for animal development, but appears to be functionally redundant for certain developmental functions with BIM. BIK is implicated in the selection of mature B cells in humans. BIK is a pro-apoptotic tumor suppressor in several human tissues and its expression in cancers is prevented by chromosomal deletions encompassing the Bik locus or by epigenetic silencing. BIK appears to be a critical effector in apoptosis induced by toxins, cytokines and virus infection. Several anti-cancer drugs transcriptionally activate Bik gene expression through transcriptional pathways dependent on factors such as E2F and p53 or by removal of epigenetic marks on the chromatin. BIK appears to be a prominent target for anti-cancer drugs that inhibit proteasomal functions. BIK has also been used as a therapeutic molecule in gene therapy-based approaches to treat difficult cancers.
Figures


Similar articles
-
Transcriptional activation of the proapoptotic bik gene by E2F proteins in cancer cells.FEBS Lett. 2006 Oct 30;580(25):5905-9. doi: 10.1016/j.febslet.2006.08.088. Epub 2006 Oct 2. FEBS Lett. 2006. PMID: 17027756
-
Bim and Bmf in tissue homeostasis and malignant disease.Oncogene. 2008 Dec;27 Suppl 1(Suppl 1):S41-52. doi: 10.1038/onc.2009.42. Oncogene. 2008. PMID: 19641506 Free PMC article. Review.
-
Suppression of the death gene BIK is a critical factor for resistance to tamoxifen in MCF-7 breast cancer cells.Int J Oncol. 2013 Dec;43(6):1777-86. doi: 10.3892/ijo.2013.2127. Epub 2013 Oct 4. Int J Oncol. 2013. PMID: 24100375 Free PMC article.
-
The BH3-only protein Bik/Blk/Nbk inhibits nuclear translocation of activated ERK1/2 to mediate IFNgamma-induced cell death.J Cell Biol. 2008 Nov 3;183(3):429-39. doi: 10.1083/jcb.200801186. J Cell Biol. 2008. PMID: 18981230 Free PMC article.
-
BH3-only proteins in apoptosis and beyond: an overview.Oncogene. 2008 Dec;27 Suppl 1(Suppl 1):S2-19. doi: 10.1038/onc.2009.39. Oncogene. 2008. PMID: 19641503 Free PMC article. Review.
Cited by
-
Src tyrosine kinase inhibits apoptosis through the Erk1/2- dependent degradation of the death accelerator Bik.Cell Death Differ. 2012 Sep;19(9):1459-69. doi: 10.1038/cdd.2012.21. Epub 2012 Mar 2. Cell Death Differ. 2012. PMID: 22388352 Free PMC article.
-
PIWI-Interacting RNA HAAPIR Regulates Cardiomyocyte Death After Myocardial Infarction by Promoting NAT10-Mediated ac4 C Acetylation of Tfec mRNA.Adv Sci (Weinh). 2022 Mar;9(8):e2106058. doi: 10.1002/advs.202106058. Epub 2022 Feb 9. Adv Sci (Weinh). 2022. PMID: 35138696 Free PMC article.
-
BIK drives an aggressive breast cancer phenotype through sublethal apoptosis and predicts poor prognosis of ER-positive breast cancer.Cell Death Dis. 2020 Jun 11;11(6):448. doi: 10.1038/s41419-020-2654-2. Cell Death Dis. 2020. PMID: 32528057 Free PMC article.
-
Identification of BIK as an unfavorable prognostic marker and novel therapeutic target in microsatellite stable colorectal cancer harboring KRAS mutations.Am J Cancer Res. 2022 Nov 15;12(11):5300-5314. eCollection 2022. Am J Cancer Res. 2022. PMID: 36504908 Free PMC article.
-
Metagenomic and single-cell RNA-Seq survey of the Helicobacter pylori-infected stomach in asymptomatic individuals.JCI Insight. 2023 Feb 22;8(4):e161042. doi: 10.1172/jci.insight.161042. JCI Insight. 2023. PMID: 36810249 Free PMC article.
References
-
- Aouacheria A, Brunet F, Gouy M. Phylogenomics of life-or-death switches in multicellular animals: Bcl-2, BH3-Only, and BNip families of apoptotic regulators. Mol Biol Evol. 2005;22:2395–2416. - PubMed
-
- Arena V, Martini M, Luongo M, Capelli A, Larocca LM. Mutations of the BIK gene in human peripheral B-cell lymphomas. Genes Chromosomes Cancer. 2003;38:91–96. - PubMed
-
- Boyd JM, Gallo GJ, Elangovan B, Houghton AB, Malstrom S, Avery BJ, et al. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene. 1995;11:1921–1928. - PubMed
-
- Boyd JM, Malstrom S, Subramanian T, Venkatesh LK, Schaeper U, Elangovan B, et al. Adenovirus E1B 19 kDa and Bcl-2 proteins interact with a common set of cellular proteins. Cell. 1994;79:341–351. - PubMed
-
- Bredel M, Bredel C, Juric D, Harsh GR, Vogel H, Recht LD, et al. High-resolution genome-wide mapping of genetic alterations in human glial brain tumors. Cancer Res. 2005;65:4088–4096. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous